FDA authorizes booster shots for those 65+ or high risk
The U.S. Food and Drug Administration Wednesday backed targeted use of booster doses of Pfizer’s COVID-19 vaccine in senior citizens and others at high risk from the coronavirus during a two-day meeting with advisers from the federal Centers for Disease Control and Prevention.
Uncertainties regarding booster shots led to some experts at the meeting suggesting the decision be postponed another month. The Associated Press called the confusion a reminder that the science surrounding the extra shots is more complicated than previously suggested.
The FDA’s authorization will allow for boosters in health care workers, teachers, grocery store workers and those in homeless shelters or prisons, according to a statement by FDA acting commissioner Janet Woodcock.
Latest COVID-19 data
South Carolina health officials reported 3,165 total cases of COVID-19 Sept. 23, with 2,202 confirmed. A total of 44 new deaths, with 39 confirmed, were also reported Thursday.
With 24,310 tests reported, 12.4% were confirmed positive.